Innate Pharma S.A.

NASDAQ: IPHA · Real-Time Price · USD
2.11
-0.07 (-3.21%)
At close: Aug 15, 2025, 3:59 PM
2.12
0.47%
After-hours: Aug 15, 2025, 04:00 PM EDT

Innate Pharma S.A. Ratios and Metrics

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.91 -28.15 -4.77 -5.39
PEG Ratio
-0.01 0.32 3.53 -0.00
PS Ratio
11.41 4.11 4.81 26.34
PB Ratio
16.30 4.11 5.12 2.97
P/FCF Ratio
-19.76 -6.1 -13.67 -5.34
P/OCF Ratio
-20.88 -6.54 -14.48 -5.46
OCF/S Ratio
-0.55 -0.63 -0.33 -4.83
Debt / Equity Ratio
3.51 0.77 0.78 0.41
Quick Ratio
2.60 3.73 3.38 1.79
Current Ratio
2.60 3.73 3.38 1.73
Asset Turnover
0.11 0.28 0.28 0.05
Interest Coverage
-91.12 -19.8 -199.39 -153.29
Return on Equity
-5.6 -0.15 -1.07 -0.55
Return on Assets
-0.45 -0.04 -0.28 -0.22
Return on Invested Capital
-0.59 -0.09 -0.34 -0.28
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 -0.08 -0.04 -2.88
Net Profit Margin
-3.92 -0.15 -1.01 -4.88
Pretax Profit Margin
-3.92 -0.15 -1.01 -3.75
Operating Profit Margin
-4.09 -0.24 -1 -3.95
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-3.72 -0.04 -0.21 -3.57